» Articles » PMID: 10521424

Cloning and Characterization of AOEB166, a Novel Mammalian Antioxidant Enzyme of the Peroxiredoxin Family

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Oct 16
PMID 10521424
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Using two-dimensional electrophoresis, we have recently identified in human bronchoalveolar lavage fluid a novel protein, termed B166, with a molecular mass of 17 kDa. Here, we report the cloning of human and rat cDNAs encoding B166, which has been renamed AOEB166 for antioxidant enzyme B166. Indeed, the deduced amino acid sequence reveals that AOEB166 represents a new mammalian subfamily of AhpC/TSA peroxiredoxin antioxidant enzymes. Human AOEB166 shares 63% similarity with Escherichia coli AhpC22 alkyl hydroperoxide reductase and 66% similarity with a recently identified Saccharomyces cerevisiae alkyl hydroperoxide reductase/thioredoxin peroxidase. Moreover, recombinant AOEB166 expressed in E. coli exhibits a peroxidase activity, and an antioxidant activity comparable with that of catalase was demonstrated with the glutamine synthetase protection assay against dithiothreitol/Fe3+/O(2) oxidation. The analysis of AOEB166 mRNA distribution in 30 different human tissues and in 10 cell lines shows that the gene is widely expressed in the body. Of interest, the analysis of N- and C-terminal domains of both human and rat AOEB166 reveals amino acid sequences presenting features of mitochondrial and peroxisomal targeting sequences. Furthermore, human AOEB166 expressed as a fusion protein with GFP in HepG2 cell line is sorted to these organelles. Finally, acute inflammation induced in rat lung by lipopolysaccharide is associated with an increase of AOEB166 mRNA levels in lung, suggesting a protective role for AOEB166 in oxidative and inflammatory processes.

Citing Articles

Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy.

Wang W, Hashimi B, Wang P Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39820644 DOI: 10.1007/s00210-025-03791-y.


Peroxiredoxin V Protects against UVB-Induced Damage of Keratinocytes.

Kim S, Park J, Lee B, Lim K, Chang T Antioxidants (Basel). 2023; 12(7).

PMID: 37507973 PMC: 10376850. DOI: 10.3390/antiox12071435.


Hydrogen peroxide detoxification through the peroxiredoxin/thioredoxin antioxidant system: A look at the pancreatic β-cell oxidant defense.

Stancill J, Corbett J Vitam Horm. 2023; 121:45-66.

PMID: 36707143 PMC: 10058777. DOI: 10.1016/bs.vh.2022.11.001.


Knockdown of Peroxiredoxin V increased the cytotoxicity of non-thermal plasma-treated culture medium to A549 cells.

Sun H, Guo X, Xie D, Wang X, Ren C, Han Y Aging (Albany NY). 2022; 14(9):4000-4013.

PMID: 35546738 PMC: 9134956. DOI: 10.18632/aging.204063.


Ferroptosis in Cancer Progression: Role of Noncoding RNAs.

Zuo Y, Zhang Y, Zhang R, Tian J, Lv X, Li R Int J Biol Sci. 2022; 18(5):1829-1843.

PMID: 35342359 PMC: 8935228. DOI: 10.7150/ijbs.66917.